Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
29
RCEL Quote, Financials, Valuation and Earnings
Last price:
$4.40
Seasonality move
:
0.49%
Day range:
$4.72 - $4.99
52-week range:
$3.22 - $10.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.71x
P/B ratio:
40.83x
Volume:
208.7K
Avg. volume:
230K
1-year change:
-42.65%
Market cap:
$134.8M
Revenue:
$71.6M
EPS (TTM):
-$1.75
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RCEL
AVITA Medical, Inc.
|
$17.4M | -$0.38 | -0.6% | -48.45% | $8.48 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $132.64 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.2M | $0.04 | 16.82% | -98.64% | $24.31 |
|
OM
Outset Medical, Inc.
|
$28.9M | -$0.68 | -3.12% | -78.85% | $10.50 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 11.45% | -97.49% | $6.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RCEL
AVITA Medical, Inc.
|
$4.40 | $8.48 | $134.8M | -- | $0.00 | 0% | 1.71x |
|
ABT
Abbott Laboratories
|
$108.03 | $132.64 | $187.7B | 29.06x | $0.63 | 2.22% | 4.26x |
|
ARAY
Accuray, Inc.
|
$0.37 | $2.53 | $44M | 149.00x | $0.00 | 0% | 0.10x |
|
ATEC
Alphatec Holdings, Inc.
|
$12.28 | $24.31 | $1.9B | -- | $0.00 | 0% | 2.41x |
|
OM
Outset Medical, Inc.
|
$3.26 | $10.50 | $57.8M | -- | $0.00 | 0% | 0.41x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.25 | $6.25 | $34.4M | -- | $0.00 | 0% | 5.63x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RCEL
AVITA Medical, Inc.
|
156.64% | -1.911 | 43.66% | 0.44x |
|
ABT
Abbott Laboratories
|
21.33% | 0.218 | 6.98% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.787 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.3% | 1.734 | 18.94% | 1.24x |
|
OM
Outset Medical, Inc.
|
44.37% | 4.636 | 153.61% | 5.40x |
|
PSTV
Plus Therapeutics, Inc.
|
17.04% | -3.087 | 1.17% | 1.09x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RCEL
AVITA Medical, Inc.
|
$14.3M | -$10.4M | -128.41% | -1112.54% | -59.09% | -$4.8M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$130.4M | -$5.4M | -23.65% | -1092.5% | -2.52% | $5.7M |
|
OM
Outset Medical, Inc.
|
$12.2M | -$17.3M | -33.49% | -65.77% | -60.07% | -$9.7M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$5.7M | -- | -- | -420.04% | -$6.3M |
AVITA Medical, Inc. vs. Competitors
-
Which has Higher Returns RCEL or ABT?
Abbott Laboratories has a net margin of -65.97% compared to AVITA Medical, Inc.'s net margin of 15.71%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital RCELAVITA Medical, Inc.81.24% -$0.38 $29.4M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About RCEL or ABT?
AVITA Medical, Inc. has a consensus price target of $8.48, signalling upside risk potential of 92.43%. On the other hand Abbott Laboratories has an analysts' consensus of $132.64 which suggests that it could grow by 22.78%. Given that AVITA Medical, Inc. has higher upside potential than Abbott Laboratories, analysts believe AVITA Medical, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings RCELAVITA Medical, Inc.3 1 0 ABTAbbott Laboratories16 7 0 -
Is RCEL or ABT More Risky?
AVITA Medical, Inc. has a beta of 1.771, which suggesting that the stock is 77.096% more volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.741, suggesting its less volatile than the S&P 500 by 25.919%.
-
Which is a Better Dividend Stock RCEL or ABT?
AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.22% to investors and pays a quarterly dividend of $0.63 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios RCEL or ABT?
AVITA Medical, Inc. quarterly revenues are $17.6M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. AVITA Medical, Inc.'s net income of -$11.6M is lower than Abbott Laboratories's net income of $1.8B. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 29.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.71x versus 4.26x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RCELAVITA Medical, Inc.1.71x -- $17.6M -$11.6M ABTAbbott Laboratories4.26x 29.06x $11.5B $1.8B
-
Which has Higher Returns RCEL or ARAY?
Accuray, Inc. has a net margin of -65.97% compared to AVITA Medical, Inc.'s net margin of -13.47%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital RCELAVITA Medical, Inc.81.24% -$0.38 $29.4M ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About RCEL or ARAY?
AVITA Medical, Inc. has a consensus price target of $8.48, signalling upside risk potential of 92.43%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 581.7%. Given that Accuray, Inc. has higher upside potential than AVITA Medical, Inc., analysts believe Accuray, Inc. is more attractive than AVITA Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RCELAVITA Medical, Inc.3 1 0 ARAYAccuray, Inc.2 0 0 -
Is RCEL or ARAY More Risky?
AVITA Medical, Inc. has a beta of 1.771, which suggesting that the stock is 77.096% more volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.192, suggesting its more volatile than the S&P 500 by 19.162%.
-
Which is a Better Dividend Stock RCEL or ARAY?
AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RCEL or ARAY?
AVITA Medical, Inc. quarterly revenues are $17.6M, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. AVITA Medical, Inc.'s net income of -$11.6M is higher than Accuray, Inc.'s net income of -$13.8M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.71x versus 0.10x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RCELAVITA Medical, Inc.1.71x -- $17.6M -$11.6M ARAYAccuray, Inc.0.10x 149.00x $102.2M -$13.8M
-
Which has Higher Returns RCEL or ATEC?
Alphatec Holdings, Inc. has a net margin of -65.97% compared to AVITA Medical, Inc.'s net margin of -10.21%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Alphatec Holdings, Inc.'s return on equity of -1092.5%.
Company Gross Margin Earnings Per Share Invested Capital RCELAVITA Medical, Inc.81.24% -$0.38 $29.4M ATECAlphatec Holdings, Inc.61.24% -$0.14 $632.1M -
What do Analysts Say About RCEL or ATEC?
AVITA Medical, Inc. has a consensus price target of $8.48, signalling upside risk potential of 92.43%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.31 which suggests that it could grow by 97.95%. Given that Alphatec Holdings, Inc. has higher upside potential than AVITA Medical, Inc., analysts believe Alphatec Holdings, Inc. is more attractive than AVITA Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RCELAVITA Medical, Inc.3 1 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is RCEL or ATEC More Risky?
AVITA Medical, Inc. has a beta of 1.771, which suggesting that the stock is 77.096% more volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.994%.
-
Which is a Better Dividend Stock RCEL or ATEC?
AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RCEL or ATEC?
AVITA Medical, Inc. quarterly revenues are $17.6M, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $212.9M. AVITA Medical, Inc.'s net income of -$11.6M is higher than Alphatec Holdings, Inc.'s net income of -$21.7M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.71x versus 2.41x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RCELAVITA Medical, Inc.1.71x -- $17.6M -$11.6M ATECAlphatec Holdings, Inc.2.41x -- $212.9M -$21.7M
-
Which has Higher Returns RCEL or OM?
Outset Medical, Inc. has a net margin of -65.97% compared to AVITA Medical, Inc.'s net margin of -67.5%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Outset Medical, Inc.'s return on equity of -65.77%.
Company Gross Margin Earnings Per Share Invested Capital RCELAVITA Medical, Inc.81.24% -$0.38 $29.4M OMOutset Medical, Inc.42.36% -$1.09 $228.2M -
What do Analysts Say About RCEL or OM?
AVITA Medical, Inc. has a consensus price target of $8.48, signalling upside risk potential of 92.43%. On the other hand Outset Medical, Inc. has an analysts' consensus of $10.50 which suggests that it could grow by 222.58%. Given that Outset Medical, Inc. has higher upside potential than AVITA Medical, Inc., analysts believe Outset Medical, Inc. is more attractive than AVITA Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RCELAVITA Medical, Inc.3 1 0 OMOutset Medical, Inc.3 1 0 -
Is RCEL or OM More Risky?
AVITA Medical, Inc. has a beta of 1.771, which suggesting that the stock is 77.096% more volatile than S&P 500. In comparison Outset Medical, Inc. has a beta of 2.126, suggesting its more volatile than the S&P 500 by 112.557%.
-
Which is a Better Dividend Stock RCEL or OM?
AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Outset Medical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Outset Medical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RCEL or OM?
AVITA Medical, Inc. quarterly revenues are $17.6M, which are smaller than Outset Medical, Inc. quarterly revenues of $28.9M. AVITA Medical, Inc.'s net income of -$11.6M is higher than Outset Medical, Inc.'s net income of -$19.5M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Outset Medical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.71x versus 0.41x for Outset Medical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RCELAVITA Medical, Inc.1.71x -- $17.6M -$11.6M OMOutset Medical, Inc.0.41x -- $28.9M -$19.5M
-
Which has Higher Returns RCEL or PSTV?
Plus Therapeutics, Inc. has a net margin of -65.97% compared to AVITA Medical, Inc.'s net margin of -417.92%. AVITA Medical, Inc.'s return on equity of -1112.54% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital RCELAVITA Medical, Inc.81.24% -$0.38 $29.4M PSTVPlus Therapeutics, Inc.93.27% -$0.04 $4.8M -
What do Analysts Say About RCEL or PSTV?
AVITA Medical, Inc. has a consensus price target of $8.48, signalling upside risk potential of 92.43%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $6.25 which suggests that it could grow by 2400%. Given that Plus Therapeutics, Inc. has higher upside potential than AVITA Medical, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than AVITA Medical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings RCELAVITA Medical, Inc.3 1 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is RCEL or PSTV More Risky?
AVITA Medical, Inc. has a beta of 1.771, which suggesting that the stock is 77.096% more volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.788, suggesting its less volatile than the S&P 500 by 21.173%.
-
Which is a Better Dividend Stock RCEL or PSTV?
AVITA Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AVITA Medical, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RCEL or PSTV?
AVITA Medical, Inc. quarterly revenues are $17.6M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. AVITA Medical, Inc.'s net income of -$11.6M is lower than Plus Therapeutics, Inc.'s net income of -$5.7M. Notably, AVITA Medical, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AVITA Medical, Inc. is 1.71x versus 5.63x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RCELAVITA Medical, Inc.1.71x -- $17.6M -$11.6M PSTVPlus Therapeutics, Inc.5.63x -- $1.4M -$5.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
92
APEI alert for Mar 13
American Public Education, Inc. [APEI] is up 26.24% over the past day.
Buy
52
PZZA alert for Mar 13
Papa John's International, Inc. [PZZA] is down 5.25% over the past day.
Buy
53
NBIS alert for Mar 13
Nebius Group NV [NBIS] is up 0.87% over the past day.
